Anna M. Fine, PharmD

Article

Do Erythropoiesis-Stimulating Agents Have a Risk Evaluation and Mitigation Strategy? (FULL)

Author:: Anna M. Fine, PharmD

Publish date: August 2, 2018

Epoetin alfa and darbepoetin alfa are erythropoiesis-stimulating agents (ESAs), approved for the treatment of anemia (low red blood cells [RBCs]) r...

Article

Abuse-Deterrent Opioids: What Practitioners Need to Know

Author:: Anna M. Fine, PharmD

Publish date: November 30, 2016

The meaning of the term abuse-deterrent is often misunderstood to mean abuse-proof. The FDA defines abuse-deterrent properties as those prope...